Legend Biotech Corp (LEGN) Total liabilities 2019–2024
Legend Biotech Corp (LEGN) total liabilities at each fiscal year-end, per SEC filings.
$629.7MFY2024 · since FY2019: $410.6M → $629.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $629.7M | +5.4% |
| FY2023 | $597.2M | +1.8% |
| FY2022 | $586.7M | +65.9% |
| FY2021 | $353.5M | +184.4% |
| FY2020 | $124.3M | -69.7% |
| FY2019 | $410.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LEGN financial trends
LEGN RevenueLEGN Net incomeLEGN Net marginLEGN Gross profitLEGN Gross marginLEGN Operating incomeLEGN Operating marginLEGN Operating cash flowLEGN Free cash flowLEGN Capital expendituresLEGN Return on equityLEGN Stock buybacksLEGN Dividends paidLEGN Total assetsLEGN Shareholders’ equityLEGN overview →